Special Issue "Advances in Research on Neurologic Related Diseases in Children"

A special issue of Children (ISSN 2227-9067). This special issue belongs to the section "Child Neurology".

Deadline for manuscript submissions: 15 September 2021.

Special Issue Editor

Dr. Vinay Puri
E-Mail Website
Guest Editor
Department of Neurology, Division of Pediatric Neurology, University of Louisville School of Medicine, Louisville, KY 40202, USA
Interests: conditions associated with dysautonomia; critical care neurology; neurological emergencies

Special Issue Information

Dear Colleagues,

Neurological problems in children are a source of great concern and anxiety to parents and caregivers. Fortunately, there have been rapid developments in our understanding of genetics which have led to the ability to define the genetic and molecular basis of many neurological disorders in children—in some cases, allowing the practice of precision medicine in areas of developmental delay, epilepsy, metabolic disorders, stroke, and neuromuscular disorders. We must keep abreast of these advances so as to care most appropriately for our patients. In addition, there have been tremendous advances in our understanding of neuroimmunology as well, which has led to much better diagnostics and therapeutics in these patients and improvements in our ability to treat disorders that were previously unrecognized.

The goal of this Special Issue of Children is to highlight recent advances in information, diagnostics, and treatment across the wide range of neurological disorders in children. We welcome reviews and original research to advance our understanding and bridge any gaps in the diagnosis and treatment of neurological disorders in children.

I look forward to receiving your contributions.

Dr. Vinay Puri
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Children is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Genetics
  • Precision Medicine
  • Neuroimmunology
  • Developmental Delay
  • Epilepsy
  • Metabolic Disorders
  • Neuromuscular Disorders
  • Stroke

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

Article
Malformations of Cortical Development, Cognitive Involvementand Epilepsy: A Single Institution Experience in 19 Young Patients
Children 2021, 8(8), 637; https://doi.org/10.3390/children8080637 - 26 Jul 2021
Viewed by 299
Abstract
Background. Malformations of cortical development (MCD) include a wide range of congenital disorders mostly causing severe cognitive dysfunction and epilepsy. Objective: to report on clinical features including cognitive involvement, epileptic seizures with response to antiseizure medications, comorbidities in young patients affected by MCD [...] Read more.
Background. Malformations of cortical development (MCD) include a wide range of congenital disorders mostly causing severe cognitive dysfunction and epilepsy. Objective: to report on clinical features including cognitive involvement, epileptic seizures with response to antiseizure medications, comorbidities in young patients affected by MCD and followed in a single tertiary hospital. Patients and methods: A retrospective review of the medical records and magnetic resonance images (MRI) of 19 young patients with an age ranging between eight days and fifteen years affected by MCD and admitted to Pediatrics Department University of Catania, Italy from October 2009 and October 2020 were selected. Patients were distinguished in three groups following the Barcovich et al. 2012 classification for MCD: 4 (21%) in Group I; 8 (42%) in Group II; and, and 7 (37%) in Group III. Clinical features and MRI of the patients including cognitive involvement, epilepsy type and response to drugs treatment were analyzed. Results: In Group I, two patients showed cortical dysplasia and two dysembryoplastic neuroepithelial tumors plus focal cortical dysplasia; developmental delay/intellectual disability (DD/ID) was severe in one, moderate in one and absent in two; the type of seizures was in all the cases focal to bilateral tonic-clonic (FBTCs), and drug resistant was found in one case. In Group II, three patients showed neuronal hetero-topias and five had pachygyria-lissencephaly: DD/ID was severe in four, moderate in two, and absent in two; the type of seizure was focal (FS) in five, focal to bilateral tonic-clonic (FBTCs) in two, infantile spasms (IS) in one, and drug resistant was found in three. In Group III, six showed polymicrogyria and one schizencephaly: DD/ID was found severe in five, moderate in two, and the type of seizure was focal (FS) in five, FBTCS in two, and drug resistance was found in three. Full article
(This article belongs to the Special Issue Advances in Research on Neurologic Related Diseases in Children)

Review

Jump to: Research

Review
Update on Acute Disseminated Encephalomyelitis in Children and Adolescents
Children 2021, 8(4), 280; https://doi.org/10.3390/children8040280 - 06 Apr 2021
Cited by 1 | Viewed by 460
Abstract
Acute disseminated encephalomyelitis (ADEM) is an immune-mediated, inflammatory demyelinating disease of the central nervous system (CNS) that usually affects children and young adults after an infection or vaccination. The presence of several conditions mimicking ADEM, added to the lack of specific biomarkers, makes [...] Read more.
Acute disseminated encephalomyelitis (ADEM) is an immune-mediated, inflammatory demyelinating disease of the central nervous system (CNS) that usually affects children and young adults after an infection or vaccination. The presence of several conditions mimicking ADEM, added to the lack of specific biomarkers, makes diagnosis potentially hard. Prompt diagnosis is necessary to start adequate treatment to improve the clinical course and long-term outcome. Because of its heterogeneity in both clinical presentation and course, challenges remain in establishing the most appropriate therapeutic approach in each patient. The aim of this review is to provide an update on management of this disease with a focus on acute treatment and to give suggestions for future research. We showed that there are currently no guidelines that help clinicians manage ADEM and therapeutic decisions are often made on a case-by-case basis. Further studies are necessary to identify clinical, laboratory, and instrumental criteria that could be correlated with outcomes and guide clinicians in choosing when and what treatment should be given in each case. Full article
(This article belongs to the Special Issue Advances in Research on Neurologic Related Diseases in Children)
Show Figures

Figure 1

Back to TopTop